Table 3.
ΔAdiponectin | ΔPlasminogen activator inhibitor-1 | |
---|---|---|
ΔHbA1c | −0.787a | 0.382a |
ΔBody weight | −0.696a | 0.435a |
ΔeGFR | 0.206 | 0.039 |
ΔAcetoacetic acid | −0.107 | −0.113 |
Δ3-hydroxybutyric acid | −0.157 | −0.063 |
ΔTotal ketone bodies | −0.145 | −0.078 |
ΔHigh-sensitivity CRP | 0.106 | −0.066 |
ΔAdiponectin | − | −0.326 |
Δ Difference from baseline to endpoint (12 weeks after treatment with dapagliflozin)
HbA1c hemoglobin A1c, eGFR estimated glomerular filtration rate, CRP C-reactive protein
a p < 0.05